Current Insights in the Development of Efficacious Vaccines Against RSV

Jorge A. Soto, Laura M. Stephens, Kody A. Waldstein, Gisela Canedo-Marroquín, Steven M. Varga, Alexis M. Kalergis*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Scopus citations
Original languageEnglish
Article number1507
JournalFrontiers in Immunology
Volume11
DOIs
StatePublished - 17 Jul 2020
Externally publishedYes

Bibliographical note

Funding Information:
This research was funded by FONDECYT 1190830, 3190590 and the Millennium Institute on Immunology and Immunotherapy P09/016-F. This work was supported by the Department of Microbiology and Immunology at the University of Iowa (to SV) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH, R01AI124093 to SV and T32AI007485 to LS).

Funding Information:
AK is a Helen C. Levitt visiting professor at the Department of Microbiology and Immunology of the University of Iowa. Funding. This research was funded by FONDECYT 1190830, 3190590 and the Millennium Institute on Immunology and Immunotherapy P09/016-F. This work was supported by the Department of Microbiology and Immunology at the University of Iowa (to SV) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH, R01AI124093 to SV and T32AI007485 to LS).

Keywords

  • antibodies
  • Respiratory Syncytial Virus
  • T cells
  • treatments
  • vaccines

Cite this